Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Fenaux

Showing results (21-30 of 432) with videos related to

Pageof 44
Sort By:
Bulletin Du Cancer|September 28, 2015
[Management of myelodysplastic syndromes]Matthieu Duchmann, Pierre Fenaux, Thomas Cluzeau
Lancet (London, England)|March 25, 2014
Myelodysplastic syndromesLionel Adès, Raphael Itzykson, Pierre Fenaux
Mediterranean Journal of Hematology and Infectious Diseases|March 7, 2015
Refractory thrombocytopenia and neutropenia: a diagnostic challengeEmmanuel Gyan, François Dreyfus, Pierre Fenaux
Seminars in Hematology|October 20, 2012
Treatment of advanced myelodysplastic syndrome with demethylating agents: azacitidineLionel Adès, Raphael Itzykson, Pierre Fenaux
British Journal of Haematology|January 26, 2008
The role of lenalidomide in the management of myelodysplasia with del 5qCharikleia Kelaidi, Virginie Eclache, Pierre Fenaux
British Journal of Haematology|October 1, 2019
How we manage adults with myelodysplastic syndromePierre Fenaux, Uwe Platzbecker, Lionel Ades
Cancers|September 23, 2022
How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic SyndromesMichael Loschi, Pierre Fenaux, Thomas Cluzeau
Best Practice & Research. Clinical Haematology|February 11, 2014
Somatic mutations and epigenetic abnormalities in myelodysplastic syndromesRaphael Itzykson, Olivier Kosmider, Pierre Fenaux
Leukemia|February 16, 2018
A decade of progress in myelodysplastic syndrome with chromosome 5q deletionAlan List, Benjamin L Ebert, Pierre Fenaux
Blood Advances|March 9, 2021
Development of luspatercept to treat ineffective erythropoiesisAnne Sophie Kubasch, Pierre Fenaux, Uwe Platzbecker
Pageof 44

Showing results (21-30 of 432) with videos related to

Sort By:
Pageof 44
Bulletin Du Cancer|September 28, 2015
[Management of myelodysplastic syndromes]Matthieu Duchmann, Pierre Fenaux, Thomas Cluzeau
Lancet (London, England)|March 25, 2014
Myelodysplastic syndromesLionel Adès, Raphael Itzykson, Pierre Fenaux
Mediterranean Journal of Hematology and Infectious Diseases|March 7, 2015
Refractory thrombocytopenia and neutropenia: a diagnostic challengeEmmanuel Gyan, François Dreyfus, Pierre Fenaux
Seminars in Hematology|October 20, 2012
Treatment of advanced myelodysplastic syndrome with demethylating agents: azacitidineLionel Adès, Raphael Itzykson, Pierre Fenaux
British Journal of Haematology|January 26, 2008
The role of lenalidomide in the management of myelodysplasia with del 5qCharikleia Kelaidi, Virginie Eclache, Pierre Fenaux
British Journal of Haematology|October 1, 2019
How we manage adults with myelodysplastic syndromePierre Fenaux, Uwe Platzbecker, Lionel Ades
Cancers|September 23, 2022
How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic SyndromesMichael Loschi, Pierre Fenaux, Thomas Cluzeau
Best Practice & Research. Clinical Haematology|February 11, 2014
Somatic mutations and epigenetic abnormalities in myelodysplastic syndromesRaphael Itzykson, Olivier Kosmider, Pierre Fenaux
Leukemia|February 16, 2018
A decade of progress in myelodysplastic syndrome with chromosome 5q deletionAlan List, Benjamin L Ebert, Pierre Fenaux
Blood Advances|March 9, 2021
Development of luspatercept to treat ineffective erythropoiesisAnne Sophie Kubasch, Pierre Fenaux, Uwe Platzbecker
Pageof 44